| Ms Laura N Luu, ARNP | |
|
2202 S Cedar St, 310, Tacoma, WA 98405 | |
| (253) 272-8148 | |
| (253) 404-0506 |
| Full Name | Ms Laura N Luu |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 20 Years |
| Location | 2202 S Cedar St, Tacoma, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578505533 | NPI | - | NPPES |
| 9644311 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | AP30006902 (Washington) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | AP30006902 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Joseph Medical Center | Tacoma, WA | Hospital |
| St Clare Hospital | Lakewood, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Franciscan Medical Group | 0547173866 | 1115 |
| Summit Consulting For Post Acute Care Llc | 7416201751 | 3 |
News Archive
In her first public statement since her organization reversed a decision to stop donating to Planned Parenthood, Nancy Brinker, the founder of Susan G. Komen for the Cure, said that "I made some mistakes" in the case, which swelled into a massive controversy. Brinker, in a letter to Washington Post columnist Sally Quinn, also noted that many commentators had blamed "culture wars" for the intensity of the criticism over the foundation's cutoff of funding.
The rapid spread of COVID-19 overwhelmed hospitals that were unable to contend with the increasing number of patients, many requiring ventilators and other critical care. Such conditions can put medical workers at risk. Now researchers are studying methods to increase hospital safety and efficacy during the pandemic.
Researchers around the world can tap into a new inter-disciplinary online database of COVID-19 research - allowing them to search for new partners, resources and funding to boost the global battle against the virus.
A group of researchers led by Professor Yoshiki SAWA of the Cardiovascular Group in the Graduate School of Medicine, Osaka University, succeeded in beating-heart surgery to repair a mitral valve.
A Novartis Pharmaceuticals Corporation Phase III study of Afinitor® (everolimus) tablets in combination with Sandostatin® LAR Depot (octreotide acetate for injectable suspension) extended median progression-free survival (PFS), or time without tumor growth, in patients with advanced carcinoid tumors compared to taking octreotide LAR alone.
› Verified 6 days ago
| Entity Name | Franciscan Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093165334 PECOS PAC ID: 0547173866 Enrollment ID: O20031111000789 |
News Archive
In her first public statement since her organization reversed a decision to stop donating to Planned Parenthood, Nancy Brinker, the founder of Susan G. Komen for the Cure, said that "I made some mistakes" in the case, which swelled into a massive controversy. Brinker, in a letter to Washington Post columnist Sally Quinn, also noted that many commentators had blamed "culture wars" for the intensity of the criticism over the foundation's cutoff of funding.
The rapid spread of COVID-19 overwhelmed hospitals that were unable to contend with the increasing number of patients, many requiring ventilators and other critical care. Such conditions can put medical workers at risk. Now researchers are studying methods to increase hospital safety and efficacy during the pandemic.
Researchers around the world can tap into a new inter-disciplinary online database of COVID-19 research - allowing them to search for new partners, resources and funding to boost the global battle against the virus.
A group of researchers led by Professor Yoshiki SAWA of the Cardiovascular Group in the Graduate School of Medicine, Osaka University, succeeded in beating-heart surgery to repair a mitral valve.
A Novartis Pharmaceuticals Corporation Phase III study of Afinitor® (everolimus) tablets in combination with Sandostatin® LAR Depot (octreotide acetate for injectable suspension) extended median progression-free survival (PFS), or time without tumor growth, in patients with advanced carcinoid tumors compared to taking octreotide LAR alone.
› Verified 6 days ago
| Entity Name | Summit Consulting For Post Acute Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922585736 PECOS PAC ID: 7416201751 Enrollment ID: O20181126002091 |
News Archive
In her first public statement since her organization reversed a decision to stop donating to Planned Parenthood, Nancy Brinker, the founder of Susan G. Komen for the Cure, said that "I made some mistakes" in the case, which swelled into a massive controversy. Brinker, in a letter to Washington Post columnist Sally Quinn, also noted that many commentators had blamed "culture wars" for the intensity of the criticism over the foundation's cutoff of funding.
The rapid spread of COVID-19 overwhelmed hospitals that were unable to contend with the increasing number of patients, many requiring ventilators and other critical care. Such conditions can put medical workers at risk. Now researchers are studying methods to increase hospital safety and efficacy during the pandemic.
Researchers around the world can tap into a new inter-disciplinary online database of COVID-19 research - allowing them to search for new partners, resources and funding to boost the global battle against the virus.
A group of researchers led by Professor Yoshiki SAWA of the Cardiovascular Group in the Graduate School of Medicine, Osaka University, succeeded in beating-heart surgery to repair a mitral valve.
A Novartis Pharmaceuticals Corporation Phase III study of Afinitor® (everolimus) tablets in combination with Sandostatin® LAR Depot (octreotide acetate for injectable suspension) extended median progression-free survival (PFS), or time without tumor growth, in patients with advanced carcinoid tumors compared to taking octreotide LAR alone.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Laura N Luu, ARNP Po Box 1241, Tacoma, WA 98401-1241 Ph: (253) 272-8148 | Ms Laura N Luu, ARNP 2202 S Cedar St, 310, Tacoma, WA 98405 Ph: (253) 272-8148 |
News Archive
In her first public statement since her organization reversed a decision to stop donating to Planned Parenthood, Nancy Brinker, the founder of Susan G. Komen for the Cure, said that "I made some mistakes" in the case, which swelled into a massive controversy. Brinker, in a letter to Washington Post columnist Sally Quinn, also noted that many commentators had blamed "culture wars" for the intensity of the criticism over the foundation's cutoff of funding.
The rapid spread of COVID-19 overwhelmed hospitals that were unable to contend with the increasing number of patients, many requiring ventilators and other critical care. Such conditions can put medical workers at risk. Now researchers are studying methods to increase hospital safety and efficacy during the pandemic.
Researchers around the world can tap into a new inter-disciplinary online database of COVID-19 research - allowing them to search for new partners, resources and funding to boost the global battle against the virus.
A group of researchers led by Professor Yoshiki SAWA of the Cardiovascular Group in the Graduate School of Medicine, Osaka University, succeeded in beating-heart surgery to repair a mitral valve.
A Novartis Pharmaceuticals Corporation Phase III study of Afinitor® (everolimus) tablets in combination with Sandostatin® LAR Depot (octreotide acetate for injectable suspension) extended median progression-free survival (PFS), or time without tumor growth, in patients with advanced carcinoid tumors compared to taking octreotide LAR alone.
› Verified 6 days ago